Pacira BioSciences (PCRX) Change in Inventory (2010 - 2026)

Pacira BioSciences' Change in Inventory history runs 17 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 129.4% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was $16.6 million, a 55.09% decrease from a year earlier, with the FY2025 full-year figure at $27.6 million, up 31.72% from the prior year.
• Change in Inventory improved to -$2.5 million in Q1 2026 per PCRX's latest filing, from -$4.8 million in the prior quarter.
• Across five years, Change in Inventory topped out at $14.4 million in Q2 2025 and bottomed at -$7.6 million in Q1 2024.
• The 5-year median for Change in Inventory is $4.4 million (2023), against an average of $3.0 million.
• Biggest YoY gain for Change in Inventory was 11988.37% in 2022; the steepest drop was 567.17% in 2022.
• Year by year, Change in Inventory stood at -$735000.0 in 2022, then soared by 1165.71% to $7.8 million in 2023, then surged by 71.29% to $13.4 million in 2024, then tumbled by 135.9% to -$4.8 million in 2025, then soared by 48.29% to -$2.5 million in 2026.
• Per Business Quant, the three latest PCRX Change in Inventory figures stand at -$2.5 million (Q1 2026), -$4.8 million (Q4 2025), and $9.5 million (Q3 2025).